Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs

Published:2017-06 Issue: Volume:115 Page:82-97
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Huang Wei,Chen Liqing,Kang Lin,Jin Mingji,Sun Ping,Xin Xin,Gao Zhonggao,Bae You Han

Funder

National Natural Science Foundation of China

Scientific Research Foundation for Young Scholar of Peking Union Medical College

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference199 articles.

1. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy;Parhi;Drug Discov. Today,2012

2. The causes and consequences of genetic heterogeneity in cancer evolution;Burrell;Nature,2013

3. Genetic heterogeneity and cancer drug resistance;Turner;Lancet Oncol.,2012

4. Drug resistance via feedback activation of Stat3 in oncogene-addicted cancer cells;Lee;Cancer Cell,2014

5. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors;Faivre;Semin. Oncol.,2006

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier-free nanomedicines: Mechanisms of formation and biomedical applications;Giant;2024-06

2. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis;ACS Applied Materials & Interfaces;2024-04-23

3. Self-targeted hyaluronic acid-b-poly (β-amino ester) pH-switchable polymersome for guided doxorubicin delivery to metastatic breast cancer;International Journal of Biological Macromolecules;2023-09

4. Exopolysaccharide (LHEPS-1) from Lactobacillus helveticus MB2-1 Induced Apoptosis and G2/M Arrest in Human Liver Cancer HepG-2 Cells;Russian Journal of Bioorganic Chemistry;2023-07-10

5. Development of pH-Responsive Hyaluronic Acid-Conjugated Cyclodextrin Nanoparticles for Chemo-/CO-Gas Dual Therapy;Pharmaceutics;2023-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3